|
시장보고서
상품코드
2149239
소화관 스텐트 시장 규모, 점유율, 성장, 세계 산업 분석, 지역별 인사이트 및 예측(2026-2034년)Gastrointestinal Stent Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
소화관 스텐트 시장 성장요인
세계 소화관 스텐트 시장 규모는 2025년 6억 1,580만 달러로 평가되며, 2026년 6억 4,780만 달러에서 2034년까지 9억 8,060만 달러로 성장하여, 예측 기간 동안 연평균 성장률(CAGR) 5.3%를 기록할 것으로 전망됩니다. 북미는 유리한 보험 환급 제도, 선진적인 의료 인프라, 그리고 최소침습성 소화관 시술의 보급 확대에 힘입어 2025년 41.88%의 점유율을 차지하며 전 세계 소화관 스텐트 시장을 주도했습니다.
소화관 스텐트란 금속, 플라스틱 또는 생분해성 소재로 만들어진 유연한 튜브로, 위, 식도, 장, 담관 등 소화관 내부에 삽입되어 폐색을 완화하는 장치입니다. 담도 질환, 식도암, 대장암 및 기타 소화기 질환의 유병률 증가에 따라 스텐트 삽입술에 대한 수요가 높아지고 있습니다.
시장의 정의 및 범위
소화관 스텐트 시장에는 소화관 폐색 및 관련 질환의 관리에 사용되는 담도용, 십이지장용, 결장용, 식도용 및 기타 스텐트가 포함됩니다. 이 시장은 소재별로는 금속, 플라스틱, 기타로, 용도별로는 담도 질환, 대장암, 염증성 장질환, 식도암, 위·십이지장암, 기타로 분류됩니다. 최종사용자로는 병원, 외래 수술 센터(ASC), 진료소 및 기타 의료 시설이 포함됩니다.
시장 역학
촉진요인 - ERCP(내시경 역행성 담췌관 조영술) 시술 건수 증가 : 내시경 역행성 담췌관 조영술(ERCP)의 시술 건수가 증가하고 있어, 소화관 스텐트, 특히 담도용 스텐트의 수요를 견인하고 있습니다. 미국에서는 연간 65만 건 이상의 ERCP 시술이 이루어지고 있으며, 이는 최소침습적 스텐트 삽입술의 활용을 촉진하고 있습니다.
억제요인 - 높은 비용과 보험 급여 제한 : 소화관 스텐트 삽입술 및 자가팽창형 금속 스텐트의 높은 비용이 도입을 저해하는 요인으로 작용하고 있습니다. 일부 국가에서의 보험 급여 제한은 의료기관이 첨단 스텐트 기술을 폭넓게 활용하는 데 더욱 걸림돌이 되고 있습니다.
기회 - 외래 수술 센터(ASC)의 확대 : 미국, 일본, 호주에서 외래 수술 센터(ASC)의 수가 증가하고 있어, 소화관 스텐트 제조사에게 기회가 생기고 있습니다. 치료용 내시경 검사가 ASC로 이전되고 있는 것은 시술의 신속화를 촉진하고, 새로운 조달 기회를 창출하고 있습니다.
동향 - 스텐트 삽입을 지지하는 임상 지침 : 대장, 식도 및 악성 담도 질환에 대한 특정 스텐트 삽입법에 대한 지지가 높아짐에 따라 표준화가 진행되고 있으며, 이는 소화관 스텐트의 보다 광범위한 채택을 촉진하고 있습니다.
과제 - 숙련된 전문가 부족 : 신흥 시장 및 저소득 국가 시장에서 숙련된 내시경 전문의와 ERCP 전문의의 수가 제한적이어서 시술 격차가 발생하고 있습니다. 소화기내과 전문의의 부족은 진단 및 치료 지연을 초래하며, 시장 확장을 저해하는 요인이 되고 있습니다.
목차
제1장 소개
제2장 주요 요약
제3장 시장 역학
제4장 주요 인사이트
제5장 세계의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제6장 북미의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제7장 유럽의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제8장 아시아태평양의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제9장 라틴아메리카의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제10장 중동 및 아프리카의 소화관 스텐트 시장 분석, 인사이트, 예측, 2021-2034년
제11장 경쟁 분석
KSM 26.10.22Growth Factors of gastrointestinal stent Market
The global gastrointestinal stent market size was valued at USD 615.8 million in 2025 and is projected to grow from USD 647.8 million in 2026 to USD 980.6 million by 2034, exhibiting a CAGR of 5.3% during the forecast period. North America dominated the global gastrointestinal stent market with a 41.88% share in 2025, supported by favorable reimbursement, advanced healthcare infrastructure, and increasing adoption of minimally invasive gastrointestinal procedures.
Gastrointestinal stents are flexible tubes made from metal, plastic, or biodegradable materials that are inserted into areas of the digestive tract, including the stomach, esophagus, intestine, or bile duct, to relieve blockages. Rising prevalence of biliary disease, esophageal cancer, colorectal cancer, and other gastrointestinal disorders is increasing demand for stenting procedures.
Market Definition and Scope
The gastrointestinal stent market includes biliary, duodenal, colonic, esophageal, and other stents used for managing gastrointestinal obstructions and related conditions. The market is segmented by material into metal, plastic, and others, and by application into biliary disease, colorectal cancer, inflammatory bowel disease, esophageal cancer, gastric/duodenal cancer, and others. End users include hospitals and ASCs, clinics, and other healthcare facilities.
Market Dynamics
Driver - Increasing ERCP Procedures: The growing number of endoscopic retrograde cholangiopancreatography procedures is driving demand for gastrointestinal stents, particularly biliary stents. More than 650,000 ERCP procedures are performed annually in the U.S., supporting the use of minimally invasive stenting procedures.
Restraint - High Cost and Limited Reimbursement: The high cost of gastrointestinal stenting procedures and self-expanding metal stents can restrict adoption. Limited reimbursement in certain countries further prevents healthcare facilities from widely utilizing advanced stenting technologies.
Opportunity - Growth of Ambulatory Surgical Centers: Increasing numbers of ASCs in the U.S., Japan, and Australia are creating opportunities for gastrointestinal stent manufacturers. The migration of therapeutic endoscopy into ASCs is supporting faster procedures and creating new procurement opportunities.
Trend - Clinical Guidelines Supporting Stenting: Increasing endorsement of specific stenting practices for colonic, esophageal, and malignant biliary conditions is improving standardization and encouraging wider adoption of gastrointestinal stents.
Challenge - Shortage of Trained Professionals: Limited availability of trained endoscopists and ERCP specialists in emerging and low-income markets creates a procedure gap. Shortages of gastroenterologists can delay diagnosis and treatment, restricting market expansion.
Segmentation Analysis
By Product Type: Biliary stents held the largest market share in 2025 due to increasing biliary stenting procedures for bile duct cancer and related conditions. Colonic stents are projected to grow at a CAGR of 5.6%.
By Material: Metal stents dominated the market in 2025 because their larger diameter provides longer patency and reduces blockage risk. The segment is expected to hold a 61.1% share in 2026. Plastic stents are projected to grow at a CAGR of 5.1%.
By Application: Biliary disease accounted for the largest share in 2025 and is expected to hold a 41.5% share in 2026, supported by the prevalence of biliary strictures and gallstone-related conditions. Esophageal cancer is projected to grow at a CAGR of 5.8%.
By End User: Hospitals and ASCs dominated in 2025 and are expected to hold a 73.2% share in 2026, owing to their greater expertise, resources, and procedure volumes. Clinics are projected to grow at a CAGR of 5.4%.
Regional Insights
North America: North America remained the leading regional market, reaching USD 257.9 million in 2025. The U.S. market is estimated to reach USD 256.0 million in 2026, supported by reimbursement and growing gastrointestinal stenting procedures.
Europe: Europe is projected to reach USD 189.2 million in 2026, recording a 5.4% growth rate. The U.K., Germany, and France are expected to reach USD 26.1 million, USD 49.7 million, and USD 24.8 million, respectively.
Asia Pacific: The region is expected to reach USD 133.8 million in 2026, with India and China estimated at USD 42.6 million and USD 14.2 million, respectively.
Latin America and Middle East & Africa: Latin America is expected to reach USD 34.8 million in 2026, while the GCC market is projected to reach USD 10.5 million, supported by growing awareness and adoption of gastrointestinal procedures.
Competitive Landscape
The market is led by Boston Scientific Corporation, Olympus Corporation, and Medtronic, supported by diversified gastrointestinal stent portfolios. Other prominent players include Merit Medical Systems, CONMED Corporation, Cook, Cardinal Health, ELLA - CS, W. L. Gore & Associates, and HOBBS MEDICAL. Companies are focusing on product commercialization, distribution expansion, approvals, acquisitions, and portfolio development.
Report Coverage
The report provides comprehensive analysis of market size and forecast for 2025, 2026, and 2034, including market dynamics, trends, opportunities, challenges, segmentation, regional analysis, procedure volumes, product approvals, technological developments, competitive landscape, company profiles, and key industry developments.
Conclusion
The global gastrointestinal stent market is projected to grow from USD 615.8 million in 2025 to USD 647.8 million in 2026 and reach USD 980.6 million by 2034. Rising ERCP procedures, increasing gastrointestinal disease burden, expansion of ASCs, and wider acceptance of minimally invasive stenting will support market growth. However, high treatment costs, reimbursement limitations, and shortages of trained professionals remain key challenges. Continued product innovation, regulatory approvals, and expansion of gastrointestinal treatment capabilities are expected to shape the market's future development.
Segmentation By Product Type, Material, Application, End-user, and Region
By Product Type
- Biliary Stents
- Duodenal Stents
- Colonic Stents
- Esophageal Stents
- Others
By Material
- Metal
- Plastic
- Others
By Application
- Biliary Disease
- Colorectal Cancer
- Inflammatory Bowel Disease
- Esophageal Cancer
- Gastric/Duodenal Cancer
- Others
By End-user
- Hospitals & ASCs
- Clinics
- Others
By Geography
- North America (By Product Type, Material, Application, End-user, and Country)
- U.S. (Product Type)
- Canada (Product Type)
- Europe (By Product Type, Material, Application, End-user, and Country/Sub-region)
- Germany (Product Type)
- U.K. (Product Type)
- France (Product Type)
- Spain (Product Type)
- Italy (Product Type)
- Scandinavia (Product Type)
- Rest of Europe (Product Type)
- Asia Pacific (By Product Type, Material, Application, End-user, and Country/Sub-region)
- China (Product Type)
- Japan (Product Type)
- India (Product Type)
- Australia (Product Type)
- Southeast Asia (Product Type)
- Rest of Asia Pacific (Product Type)
- Latin America (By Size, Procedure, End-user and Country/Sub-region)
- Brazil (Product Type)
- Mexico (Product Type)
- Rest of Latin America (Product Type)
- Middle East & Africa (By Product Type, Material, Application, End-user, and Country/Sub-region)
- GCC (Product Type)
- South Africa (Product Type)
- Rest of the Middle East & Africa (Product Type)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. Prevalence of Key Diseases, by Key Countries/Region, 2025
- 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, etc.)
- 4.3. Advancements in Gastrointestinal Stent
5. Global Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Product Type
- 5.1.1. Biliary Stents
- 5.1.2. Duodenal Stents
- 5.1.3. Colonic Stents
- 5.1.4. Esophageal Stents
- 5.1.5. Others
- 5.2. Market Analysis, Insights and Forecast - By Material
- 5.2.1. Metal
- 5.2.2. Plastic
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast - By Application
- 5.3.1. Biliary Disease
- 5.3.2. Colorectal Cancer
- 5.3.3. Inflammatory Bowel Disease
- 5.3.4. Esophageal Cancer
- 5.3.5. Gastric/Duodenal Cancer
- 5.3.6. Others
- 5.4. Market Analysis, Insights and Forecast - By End-user
- 5.4.1. Hospitals & ASCs
- 5.4.2. Clinics
- 5.4.3. Others
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Product Type
- 6.1.1. Biliary Stents
- 6.1.2. Duodenal Stents
- 6.1.3. Colonic Stents
- 6.1.4. Esophageal Stents
- 6.1.5. Others
- 6.2. Market Analysis, Insights and Forecast - By Material
- 6.2.1. Metal
- 6.2.2. Plastic
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast - By Application
- 6.3.1. Biliary Disease
- 6.3.2. Colorectal Cancer
- 6.3.3. Inflammatory Bowel Disease
- 6.3.4. Esophageal Cancer
- 6.3.5. Gastric/Duodenal Cancer
- 6.3.6. Others
- 6.4. Market Analysis, Insights and Forecast - By End-user
- 6.4.1. Hospitals & ASCs
- 6.4.2. Clinics
- 6.4.3. Others
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.1.1. Product Type
- 6.5.2. Canada
- 6.5.2.1. Product Type
- 6.5.1. U.S.
7. Europe Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Product Type
- 7.1.1. Biliary Stents
- 7.1.2. Duodenal Stents
- 7.1.3. Colonic Stents
- 7.1.4. Esophageal Stents
- 7.1.5. Others
- 7.2. Market Analysis, Insights and Forecast - By Material
- 7.2.1. Metal
- 7.2.2. Plastic
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast - By Application
- 7.3.1. Biliary Disease
- 7.3.2. Colorectal Cancer
- 7.3.3. Inflammatory Bowel Disease
- 7.3.4. Esophageal Cancer
- 7.3.5. Gastric/Duodenal Cancer
- 7.3.6. Others
- 7.4. Market Analysis, Insights and Forecast - By End-user
- 7.4.1. Hospitals & ASCs
- 7.4.2. Clinics
- 7.4.3. Others
- 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.5.1. U.K.
- 7.5.1.1. Product Type
- 7.5.2. Germany
- 7.5.2.1. Product Type
- 7.5.3. France
- 7.5.3.1. Product Type
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.5.1. Product Type
- 7.5.6. Scandinavia
- 7.5.6.1. Product Type
- 7.5.7. Rest of Europe
- 7.5.7.1. Product Type
- 7.5.1. U.K.
8. Asia Pacific Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Product Type
- 8.1.1. Biliary Stents
- 8.1.2. Duodenal Stents
- 8.1.3. Colonic Stents
- 8.1.4. Esophageal Stents
- 8.1.5. Others
- 8.2. Market Analysis, Insights and Forecast - By Material
- 8.2.1. Metal
- 8.2.2. Plastic
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast - By Application
- 8.3.1. Biliary Disease
- 8.3.2. Colorectal Cancer
- 8.3.3. Inflammatory Bowel Disease
- 8.3.4. Esophageal Cancer
- 8.3.5. Gastric/Duodenal Cancer
- 8.3.6. Others
- 8.4. Market Analysis, Insights and Forecast - By End-user
- 8.4.1. Hospitals & ASCs
- 8.4.2. Clinics
- 8.4.3. Others
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.1.1. Product Type
- 8.5.2. China
- 8.5.2.1. Product Type
- 8.5.3. Australia
- 8.5.3.1. Product Type
- 8.5.4. India
- 8.5.4.1. Product Type
- 8.5.5. Southeast Asia
- 8.5.5.1. Product Type
- 8.5.6. Rest of Asia Pacific
- 8.5.6.1. Product Type
- 8.5.1. Japan
9. Latin America Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Product Type
- 9.1.1. Biliary Stents
- 9.1.2. Duodenal Stents
- 9.1.3. Colonic Stents
- 9.1.4. Esophageal Stents
- 9.1.5. Others
- 9.2. Market Analysis, Insights and Forecast - By Material
- 9.2.1. Metal
- 9.2.2. Plastic
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast - By Application
- 9.3.1. Biliary Disease
- 9.3.2. Colorectal Cancer
- 9.3.3. Inflammatory Bowel Disease
- 9.3.4. Esophageal Cancer
- 9.3.5. Gastric/Duodenal Cancer
- 9.3.6. Others
- 9.4. Market Analysis, Insights and Forecast - By End-user
- 9.4.1. Hospitals & ASCs
- 9.4.2. Clinics
- 9.4.3. Others
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.1.1. Product Type
- 9.5.2. Mexico
- 9.5.2.1. Product Type
- 9.5.3. Rest of Latin America
- 9.5.3.1. Product Type
- 9.5.1. Brazil
10. Middle East & Africa Gastrointestinal Stent Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Product Type
- 10.1.1. Biliary Stents
- 10.1.2. Duodenal Stents
- 10.1.3. Colonic Stents
- 10.1.4. Esophageal Stents
- 10.1.5. Others
- 10.2. Market Analysis, Insights and Forecast - By Material
- 10.2.1. Metal
- 10.2.2. Plastic
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast - By Application
- 10.3.1. Biliary Disease
- 10.3.2. Colorectal Cancer
- 10.3.3. Inflammatory Bowel Disease
- 10.3.4. Esophageal Cancer
- 10.3.5. Gastric/Duodenal Cancer
- 10.3.6. Others
- 10.4. Market Analysis, Insights and Forecast - By End-user
- 10.4.1. Hospitals & ASCs
- 10.4.2. Clinics
- 10.4.3. Others
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. South Africa
- 10.5.1.1. Product Type
- 10.5.2. GCC
- 10.5.2.1. Product Type
- 10.5.3. Rest of Middle East & Africa
- 10.5.3.1. Product Type
- 10.5.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Olympus Corporation
- 11.2.2. Boston Scientific Corporation
- 11.2.3. CONMED Corporation
- 11.2.4. Cook
- 11.2.5. Medtronic
- 11.2.6. ELLA - CS, s.r.o.
- 11.2.7. W. L. Gore & Associates, Inc.
- 11.2.8. Merit Medical Systems
- 11.2.9. HOBBS MEDICAL INC.
